Prudential Financial »

Prelude Therapeutics shares owned by Prudential Financial

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Prudential Financial from 13F filings

Historical chart of Prudential Financial investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Prudential Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Prudential Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $37k 26k 1.44

More positions owned by Prudential Financial

NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Dimensional Etf Trust Us Equity Marke (DFUS)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Pgim Etf Tr Aaa Clo Etf (PAAA)
Alphabet Cap Stk Cl A (GOOGL)
Pgim Etf Tr Pgim Ultra Sh B (PULS)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Prudential Financial

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
Millennium Management
Vanguard Group
Renaissance Technologies
Acadian Asset Management
Morgan Stanley
BlackRock
Two Sigma Advisers
Geode Capital Management
TD Asset Management
Two Sigma Investments
Shay Capital
State Street Corporation
Goldman Sachs Group

View all funds holding Prelude Therapeutics